Fig. 1: Multivariable-adjusted hepatocellular carcinoma (HCC)-free probability curves according to statin use within 6 months after baseline health examination. | British Journal of Cancer

Fig. 1: Multivariable-adjusted hepatocellular carcinoma (HCC)-free probability curves according to statin use within 6 months after baseline health examination.

From: Higher cholesterol levels, not statin use, are associated with a lower risk of hepatocellular carcinoma

Fig. 1

The first 6 months of follow-up were excluded to minimise immortal time bias. HCC-free probability and 95% confidence intervals were calculated using Cox proportional hazard models after adjustment for age at baseline, sex, pre-existing diabetes, smoking status, alcohol use, physical activity, hepatitis B virus infection, hepatitis C virus infection, liver cirrhosis, body mass index, alanine aminotransferase levels, and total cholesterol levels (when applicable).

Back to article page